Internal medicine Gastroenterology

News

13 Mar 2025
Effective treatment of gastric cancer-bacterial infections begins with understanding differing clinical methods
A questionnaire translated into Japanese can help practitioners understand psychological effects on esophageal symptoms.
21 Feb 2025
Verifying the Esophageal Hypervigilance and Anxiety Scale for clinical use
Digestive disorders and other life factors are found to contribute to chronic belching.
29 Aug 2024
Survey of 10,000 Japanese adults reveal leading causes of burp-related disorders
29 Jul 2024
A research group led by Associate Professor Katsuya Sakai, Researcher Nichole Marcela Rojas-Chaverra, and Professor Kunio Matsumoto of the Cancer Research Institute and Nano-Life Science (WPI-NanoLSI) at Kanazawa University has developed a long-acting, subcutaneously injectable artificial hepatocyte growth factor (HGF) mimetic molecule using a fusion technology of cyclic peptides and protein engineering. They demonstrated in a mouse model that it improves liver fibrosis, lipid accumulation, and inflammation caused by non-alcoholic steatohepatitis (NASH). This research result provides an option for the development of NASH therapeutics as well as a technology for creating growth factor and cytokine mimetic molecules with improved pharmacokinetics.
Chronic allergic disorder eosinophilic esophagitis (EoE)
09 Jul 2024
First epidemiological study on incidence of EoE in Japan
09 Nov 2023
Researchers at Kanazawa University report in Cancer Research how Kras and p53 mutations influence the tumor suppressor and promoter functions of a TGF- ß pathway. The findings may lead to a new approach for colorectal cancer therapy.
Monitoring participants’ brain activity while viewing food images.
11 Sep 2023
Patients with a specific form of chronic indigestion react differently to images of food, compared to healthy control subjects or patients with irritable bowel syndrome.
24 Nov 2021
Researchers from the Osaka City University Graduate School of Medicine have shown in patients with early-stage hepatocellular carcinoma who received cancer treatment that eliminating the hepatitis C virus with a direct-acting antiviral treatment reduces the risk of the liver cancer progression and increases overall patient survival.
12 Feb 2021
In a study published in Nature Communications, cancer researchers at Kanazawa University identify mechanisms by which malignant tumor cells extend their toxicity to distinct cell types and in turn help them spread.

Events

Sorry, nothing coming up for this discipline

Researchers

Sorry, nothing coming up for this discipline

Giants in history

Sorry, nothing coming up for this discipline